AIM: To provide insight into professionals' opinions on breast cancer follow-up to facilitate implementation of new follow-up strategies. The study focuses on current practice, purpose and perceived effects, and preferred frequency and duration of follow-up. DESIGN: A 29-item questionnaire on professionals' demographics, current practice, opinion on the current guideline, preferences in frequency and duration of tailored follow-up, and the purpose and perceived effects of follow-up was sent to 633 Dutch professionals. RESULTS: The current national guideline is followed by 81% of respondents. All different specialists are involved in follow-up. Sixty-nine percent of respondents' report nurse practitioners to be involved in follow-up. When asked for tailored follow-up, professionals indicate more factors for increased follow-up (age<40 years, pT3-4 tumour, pN2-3, treatment related morbidity, and psychosocial support), than for reduced schedules (age >70 years and DCIS histology). Alternative forms of follow-up are not endorsed by >90% of respondents. Detection of a new primary tumour of the breast is considered the most important purpose of follow-up (98%), 57% still indicates detecting metastases as a goal. CONCLUSIONS: Professionals tend towards longer and more intensive follow-up than the current guideline for a large group of patients. Limitations and developments in follow-up need to be considered to facilitate alternative follow-up strategies.
AIM: To provide insight into professionals' opinions on breast cancer follow-up to facilitate implementation of new follow-up strategies. The study focuses on current practice, purpose and perceived effects, and preferred frequency and duration of follow-up. DESIGN: A 29-item questionnaire on professionals' demographics, current practice, opinion on the current guideline, preferences in frequency and duration of tailored follow-up, and the purpose and perceived effects of follow-up was sent to 633 Dutch professionals. RESULTS: The current national guideline is followed by 81% of respondents. All different specialists are involved in follow-up. Sixty-nine percent of respondents' report nurse practitioners to be involved in follow-up. When asked for tailored follow-up, professionals indicate more factors for increased follow-up (age<40 years, pT3-4 tumour, pN2-3, treatment related morbidity, and psychosocial support), than for reduced schedules (age >70 years and DCIS histology). Alternative forms of follow-up are not endorsed by >90% of respondents. Detection of a new primary tumour of the breast is considered the most important purpose of follow-up (98%), 57% still indicates detecting metastases as a goal. CONCLUSIONS: Professionals tend towards longer and more intensive follow-up than the current guideline for a large group of patients. Limitations and developments in follow-up need to be considered to facilitate alternative follow-up strategies.
Authors: Heather B Neuman; Nicole M Steffens; Nora Jacobson; Amye Tevaarwerk; Bethany Anderson; Lee G Wilke; Caprice C Greenberg Journal: Ann Surg Oncol Date: 2015-10-16 Impact factor: 5.344
Authors: S Feiten; J Dünnebacke; V Friesenhahn; J Heymanns; H Köppler; R Meister; J Thomalla; C van Roye; D Wey; R Weide Journal: Geburtshilfe Frauenheilkd Date: 2016-05 Impact factor: 2.915
Authors: Lesly A Dossett; Janella N Hudson; Arden M Morris; M Catherine Lee; Richard G Roetzheim; Michael D Fetters; Gwendolyn P Quinn Journal: CA Cancer J Clin Date: 2016-10-11 Impact factor: 508.702
Authors: Jinn-Tsong Tsai; Ming-Feng Hou; Yao-Mei Chen; Thomas T H Wan; Hao-Yun Kao; Hon-Yi Shi Journal: Support Care Cancer Date: 2012-12-01 Impact factor: 3.603
Authors: Heather B Neuman; Paul J Rathouz; Emily Winslow; Jennifer M Weiss; Noelle K LoConte; Chee Paul Lin; Mike Wurm; Maureen A Smith; Deborah Schrag; Caprice C Greenberg Journal: J Eval Clin Pract Date: 2016-03-17 Impact factor: 2.431
Authors: Heather B Neuman; Jennifer M Weiss; Deborah Schrag; Katie Ronk; Jeffrey Havlena; Noelle K LoConte; Maureen A Smith; Caprice C Greenberg Journal: Ann Surg Oncol Date: 2013-08-14 Impact factor: 5.344